Phosphorylation of Targeting Protein for Xenopus Kinesin-like Protein 2 (TPX2) at Threonine 72 in Spindle Assembly*
暂无分享,去创建一个
[1] I. Vernos,et al. Non-centrosomal TPX2-Dependent Regulation of the Aurora A Kinase: Functional Implications for Healthy and Pathological Cell Division , 2016, Front. Oncol..
[2] Gernot Neumayer,et al. TPX2 Impacts Acetylation of Histone H4 at Lysine 16: Implications for DNA Damage Response , 2014, PloS one.
[3] Gernot Neumayer,et al. TPX2: of spindle assembly, DNA damage response, and cancer , 2014, Cellular and Molecular Life Sciences.
[4] T. Mitchison,et al. Branching Microtubule Nucleation in Xenopus Egg Extracts Mediated by Augmin and TPX2 , 2013, Cell.
[5] Takeshi Tomonaga,et al. Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. , 2013, Journal of proteome research.
[6] M. Peng,et al. Toward a comprehensive characterization of a human cancer cell phosphoproteome. , 2013, Journal of proteome research.
[7] M. Malumbres,et al. Mitotic Stress and Chromosomal Instability in Cancer: The Case for TPX2. , 2012, Genes & cancer.
[8] H. van Attikum,et al. Targeting Protein for Xenopus Kinesin-like Protein 2 (TPX2) Regulates γ-Histone 2AX (γ-H2AX) Levels upon Ionizing Radiation* , 2012, The Journal of Biological Chemistry.
[9] Sven Diederichs,et al. The hallmarks of cancer , 2012, RNA biology.
[10] B. Maček,et al. Global Detection of Protein Kinase D-dependent Phosphorylation Events in Nocodazole-treated Human Cells* , 2012, Molecular & Cellular Proteomics.
[11] M. Malumbres,et al. Tpx2 controls spindle integrity, genome stability, and tumor development. , 2012, Cancer research.
[12] H. Daub,et al. Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells. , 2012, Journal of proteomics.
[13] Mark A van de Wiel,et al. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression , 2011, Gut.
[14] Bin Zhang,et al. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse , 2011, Nucleic Acids Res..
[15] P. Lavia,et al. Aurora-A inactivation causes mitotic spindle pole fragmentation by unbalancing microtubule-generated forces , 2011, Molecular Cancer.
[16] P. Wadsworth,et al. TPX2 regulates the localization and activity of Eg5 in the mammalian mitotic spindle , 2011, The Journal of cell biology.
[17] Otto Hudecz,et al. Quantitative Phospho-proteomics to Investigate the Polo-like Kinase 1-Dependent Phospho-proteome* , 2011, Molecular & Cellular Proteomics.
[18] Devin K Schweppe,et al. Quantitative Phosphoproteomics Identifies Substrates and Functional Modules of Aurora and Polo-Like Kinase Activities in Mitotic Cells , 2011, Science Signaling.
[19] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[20] P. Lavia,et al. Control of Aurora-A stability through interaction with TPX2 , 2011, Journal of Cell Science.
[21] Giulia Guarguaglini,et al. The Aurora-A/TPX2 complex: a novel oncogenic holoenzyme? , 2010, Biochimica et biophysica acta.
[22] D. Compton,et al. Mechanisms of Chromosomal Instability , 2010, Current Biology.
[23] S. Brunak,et al. Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis , 2010, Science Signaling.
[24] E. Nigg,et al. Quantitative analysis of the human spindle phosphoproteome at distinct mitotic stages. , 2009, Journal of proteome research.
[25] Jimmy K. Eng,et al. Quantitative Phosphoproteomic Analysis of T Cell Receptor Signaling Reveals System-Wide Modulation of Protein-Protein Interactions , 2009, Science Signaling.
[26] A. Lewellyn,et al. Phosphorylation of TPX2 by Plx1 enhances activation of Aurora A , 2009, Cell cycle.
[27] J. Yates,et al. CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. , 2009, Cancer research.
[28] Ruedi Aebersold,et al. Identification of CDK2 substrates in human cell lysates , 2008, Genome Biology.
[29] M. Mann,et al. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. , 2008, Molecular cell.
[30] S. Elledge,et al. A quantitative atlas of mitotic phosphorylation , 2008, Proceedings of the National Academy of Sciences.
[31] Patrick A. Eyers,et al. Spindle Pole Regulation by a Discrete Eg5-Interacting Domain in TPX2 , 2008, Current Biology.
[32] R. Margolis,et al. Mitosis persists in the absence of Cdk1 activity when proteolysis or protein phosphatase activity is suppressed , 2007, The Journal of cell biology.
[33] K. Fukui,et al. Nucleolin functions in nucleolus formation and chromosome congression , 2007, Journal of Cell Science.
[34] Z. Szallasi,et al. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers , 2006, Nature Genetics.
[35] Erich A Nigg,et al. Phosphoproteome analysis of the human mitotic spindle. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[36] S. Stewart,et al. Anaphase-Promoting Complex/Cyclosome Controls the Stability of TPX2 during Mitotic Exit , 2005, Molecular and Cellular Biology.
[37] R. Pepperkok,et al. Characterization of the TPX2 domains involved in microtubule nucleation and spindle assembly in Xenopus egg extracts. , 2004, Molecular biology of the cell.
[38] J. Maller,et al. Regulation of Xenopus Aurora A Activation by TPX2* , 2004, Journal of Biological Chemistry.
[39] A. Wilde,et al. Ran modulates spindle assembly by regulating a subset of TPX2 and Kid activities including Aurora A activation , 2003, Journal of Cell Science.
[40] Richard Bayliss,et al. Structural basis of Aurora-A activation by TPX2 at the mitotic spindle. , 2003, Molecular cell.
[41] A. Hoenger,et al. Importin α‐regulated nucleation of microtubules by TPX2 , 2003 .
[42] T. Kapoor,et al. hTPX2 Is Required for Normal Spindle Morphology and Centrosome Integrity during Vertebrate Cell Division , 2002, Current Biology.
[43] R. Pepperkok,et al. Chromosome-induced microtubule assembly mediated by TPX2 is required for spindle formation in HeLa cells , 2002, Nature Cell Biology.
[44] Roman Körner,et al. Human TPX2 is required for targeting Aurora-A kinase to the spindle , 2002, The Journal of cell biology.
[45] J. Julien,et al. Deregulation of Cdk5 in a Mouse Model of ALS Toxicity Alleviated by Perikaryal Neurofilament Inclusions , 2001, Neuron.
[46] Timothy J. Mitchison,et al. Probing Spindle Assembly Mechanisms with Monastrol, a Small Molecule Inhibitor of the Mitotic Kinesin, Eg5 , 2000, The Journal of cell biology.
[47] Eric Karsenti,et al. Tpx2, a Novel Xenopus Map Involved in Spindle Pole Organization , 2000, The Journal of cell biology.
[48] D. N. Perkins,et al. Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.
[49] H. Pant,et al. Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[50] I. Vernos,et al. Localization of the Kinesin-like Protein Xklp2 to Spindle Poles Requires a Leucine Zipper, a Microtubule-associated Protein, and Dynein , 1998, The Journal of cell biology.
[51] Brian Schryver,et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers , 1998, The EMBO journal.
[52] R. Liem,et al. Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. , 1998, Journal of neurobiology.
[53] R. Parwaresch,et al. p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M. , 1997, Blood.
[54] L. Meijer,et al. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. , 1997, Journal of medicinal chemistry.
[55] S H Kim,et al. Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. , 1997, European journal of biochemistry.
[56] L. Tsai,et al. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 , 1994, Nature.
[57] J. Labbé,et al. Mitosis-specific phosphorylation of nucleolin by p34cdc2 protein kinase , 1990, Molecular and cellular biology.
[58] J. Labbé,et al. Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase , 1990, Cell.
[59] J. Sarkaria,et al. Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma , 2016, Journal of Neuro-Oncology.
[60] A. Venkitaraman,et al. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. , 2003, Cancer cell.
[61] L Meijer,et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. , 1997, European journal of biochemistry.